Suppr超能文献

肛痿塞是治疗复杂肛痿的一种有效替代选择,具有长期疗效。

Anal fistula plug is a valid alternative option for the treatment of complex anal fistula in the long term.

机构信息

Surgery Unit, Casa di Cura San Pio X, Via Francesco Nava, 31, 20159, Milan, Italy.

出版信息

Int J Colorectal Dis. 2010 Dec;25(12):1487-93. doi: 10.1007/s00384-010-0957-y. Epub 2010 Jun 17.

Abstract

OBJECTIVE

This prospective, two-centre study was designed to evaluate long-term outcomes when using a collagen plug to treat cryptoglandular anal fistulae.

MATERIALS AND METHOD

Over 3 years, 60 consecutive patients with cryptoglandular fistulae were treated using an anal fistula plug by experienced surgeons. Preoperative, postoperative and follow-up data were collected in a dedicated database. Success was defined as the closure of all fistula openings and the absence of discharge. Faecal incontinence scores were administered at baseline and at 6 months follow-up.

RESULTS

Eleven patients had multiple fistula tracts. All fistulae treated in this series were classified as complex. Seventeen fistulae were anterior tracts in females, and the remaining tracts were trans-sphincteric in nature. Thirty-eight tracts were recurrent. Mean operative time was 26 ± 10 min. No major complications, active sepsis or mortality were observed. Success rate with a mean follow-up of 13 months was 60% of patients and 70% of tracts. Mean time for recurrence was 5.7 months. Two recurrent patients were successfully treated with a redo plug procedure, and five were successfully closed with a post-plug fistulotomy, leading to a global 72% success rate without continence impairment. Of the patients with a minimum follow-up of 6 months (mean, 18.5 months; range, 6-34 months), 29 in 32 (90.6%) were healed at final evaluation. In these patients, the mean preoperative CCF incontinence score was 0.73. This was reduced to 0.14 at 6-month follow-up. The mean reduction of CCF incontinence score was -0.6 (95% CI, 1.3 to -0.1; p = 0.01).

CONCLUSION

Fistula tract treatment with the anal fistula plug is a safe and viable surgical option that should be offered to complex fistula patients. The reasons and risk factors for recurrence remain to be explored.

摘要

目的

本前瞻性、双中心研究旨在评估使用胶原塞治疗隐匿性肛腺肛瘘的长期疗效。

材料和方法

在 3 年期间,由经验丰富的外科医生使用肛门瘘管塞治疗 60 例连续隐匿性肛腺瘘患者。收集术前、术后和随访数据,并录入专门的数据库。成功定义为所有瘘管开口闭合且无分泌物。在基线和 6 个月随访时进行粪便失禁评分。

结果

11 例患者存在多个瘘管。本研究中治疗的所有瘘管均被归类为复杂性。女性瘘管 17 例为前位,其余瘘管为经括约肌性。38 例为复发性瘘管。平均手术时间为 26±10 分钟。未观察到主要并发症、活动性脓毒症或死亡。平均随访 13 个月时,60%的患者和 70%的瘘管成功。复发的平均时间为 5.7 个月。2 例复发性患者通过再次使用塞栓治疗成功,5 例通过塞栓后瘘管切开术成功闭合,总成功率为 72%,且无失禁损害。在至少随访 6 个月(平均随访 18.5 个月,范围 6-34 个月)的患者中,32 例中有 29 例(90.6%)在最终评估时痊愈。这些患者术前 CCF 失禁评分平均为 0.73,随访 6 个月时降至 0.14。CCF 失禁评分平均降低 0.6(95%CI,1.3 至-0.1;p=0.01)。

结论

使用肛门瘘管塞治疗瘘管是一种安全可行的手术选择,应向复杂性瘘管患者提供。复发的原因和危险因素仍有待探讨。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验